The prevalence of sarcopenia and subtypes in cardiovascular diseases, and a new diagnostic approach

•Cardiovascular disease (CVD) lowers motor function, and especially in females.•CVD accelerates sarcopenia even if the patients are comparatively young.•CVD accelerates osteosarcopenia in females.•Our diagnostic approach for sarcopenia may help to early suppress sarcopenia in CVD. The prevalence of...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of cardiology 2020-09, Vol.76 (3), p.266-272
Hauptverfasser: Sasaki, Ken-ichiro, Kakuma, Tatsuyuki, Sasaki, Motoki, Ishizaki, Yuta, Fukami, Ako, Enomoto, Mika, Adachi, Hisashi, Matsuse, Hiroo, Shiba, Naoto, Ueno, Takafumi, Fukumoto, Yoshihiro
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:•Cardiovascular disease (CVD) lowers motor function, and especially in females.•CVD accelerates sarcopenia even if the patients are comparatively young.•CVD accelerates osteosarcopenia in females.•Our diagnostic approach for sarcopenia may help to early suppress sarcopenia in CVD. The prevalence of sarcopenia and its subtypes, such as sarcopenic obesity, osteosarcopenia, and osteosarcopenic obesity, is little known in patients with cardiovascular diseases (CVD). Physical, motor functional, and nutritional assessments were performed for 230 community-dwelling (CD) adults who came to receive a physical check-up, and 160 patients with CVD who were admitted to our hospital. Sarcopenia was diagnosed according to the Asian Working Group for Sarcopenia guidelines. The subtypes of sarcopenia were consecutively diagnosed according to increased body fat percentage and decreased bone density. The CVD patients had malnutrition when compared to the CD adults. Impaired motor function of the CVD patients occurred in females as compared with males. The prevalence of sarcopenia, osteosarcopenia, and osteosarcopenic obesity was higher in the CVD patients than in the CD adults (16.9% vs. 4.4%, p
ISSN:0914-5087
1876-4738
DOI:10.1016/j.jjcc.2020.03.004